165 related articles for article (PubMed ID: 23178558)
1. Etanercept attenuates collagen-induced arthritis by modulating the association between BAFFR expression and the production of splenic memory B cells.
Wang QT; Wu YJ; Huang B; Ma YK; Song SS; Zhang LL; Chen JY; Wu HX; Sun WY; Wei W
Pharmacol Res; 2013 Feb; 68(1):38-45. PubMed ID: 23178558
[TBL] [Abstract][Full Text] [Related]
2. Decoy receptor 3 attenuates collagen-induced arthritis by modulating T cell activation and B cell expansion.
Cheng CP; Sytwu HK; Chang DM
J Rheumatol; 2011 Dec; 38(12):2522-35. PubMed ID: 21885501
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of TACI-Ig with TNF-alpha inhibitor and methotrexate in DBA/1 mice with collagen-induced arthritis.
Zhang L; Li P; Song S; Liu Y; Wang Q; Chang Y; Wu Y; Chen J; Zhao W; Zhang Y; Zhou A; Wei W
Eur J Pharmacol; 2013 May; 708(1-3):113-23. PubMed ID: 23454555
[TBL] [Abstract][Full Text] [Related]
4. Torilin ameliorates type II collagen-induced arthritis in mouse model of rheumatoid arthritis.
Endale M; Lee WM; Kwak YS; Kim NM; Kim BK; Kim SH; Cho J; Kim S; Park SC; Yun BS; Ko D; Rhee M
Int Immunopharmacol; 2013 Jun; 16(2):232-42. PubMed ID: 23623942
[TBL] [Abstract][Full Text] [Related]
5. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
[TBL] [Abstract][Full Text] [Related]
6. Kirenol exerts a potent anti-arthritic effect in collagen-induced arthritis by modifying the T cells balance.
Lu Y; Xiao J; Wu ZW; Wang ZM; Hu J; Fu HZ; Chen YY; Qian RQ
Phytomedicine; 2012 Jul; 19(10):882-9. PubMed ID: 22673798
[TBL] [Abstract][Full Text] [Related]
7. Longterm protection of mice against collagen-induced arthritis after short-term LF 15-0195 treatment: modulation of B and T lymphocyte activation.
Ducoroy P; de Fornel D; Dubrez-Daloz L; Solary E; Dutartre P
J Rheumatol; 2003 May; 30(5):918-25. PubMed ID: 12734883
[TBL] [Abstract][Full Text] [Related]
8. Comparable therapeutic potential of umbilical cord mesenchymal stem cells in collagen-induced arthritis to TNF inhibitor or anti-CD20 treatment.
Sun Y; Kong W; Huang S; Shi B; Zhang H; Chen W; Zhang H; Zhao C; Tang X; Yao G; Feng X; Sun L
Clin Exp Rheumatol; 2017; 35(2):288-295. PubMed ID: 28094754
[TBL] [Abstract][Full Text] [Related]
9. Influence of polysaccharide fractions isolated from Caltha palustris L. on the cellular immune response in collagen-induced arthritis (CIA) in mice. A comparison with methotrexate.
Suszko A; Obmińska-Mrukowicz B
J Ethnopharmacol; 2013 Jan; 145(1):109-17. PubMed ID: 23123796
[TBL] [Abstract][Full Text] [Related]
10. Induced production of anti-etanercept antibody in collagen-induced arthritis.
Yi H; Kim J; Jung H; Rim YA; Kim Y; Jung SM; Park SH; Ju JH
Mol Med Rep; 2014 Jun; 9(6):2301-8. PubMed ID: 24718553
[TBL] [Abstract][Full Text] [Related]
11. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
12. CEL-2000: A therapeutic vaccine for rheumatoid arthritis arrests disease development and alters serum cytokine/chemokine patterns in the bovine collagen type II induced arthritis in the DBA mouse model.
Zimmerman DH; Taylor P; Bendele A; Carambula R; Duzant Y; Lowe V; O'Neill SP; Talor E; Rosenthal KS
Int Immunopharmacol; 2010 Apr; 10(4):412-21. PubMed ID: 20074669
[TBL] [Abstract][Full Text] [Related]
13. Paeoniflorin-6'-O-benzene sulfonate alleviates collagen-induced arthritis in mice by downregulating BAFF-TRAF2-NF-κB signaling: comparison with biological agents.
Shu JL; Zhang XZ; Han L; Zhang F; Wu YJ; Tang XY; Wang C; Tai Y; Wang QT; Chen JY; Chang Y; Wu HX; Zhang LL; Wei W
Acta Pharmacol Sin; 2019 Jun; 40(6):801-813. PubMed ID: 30446734
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
[TBL] [Abstract][Full Text] [Related]
15. Combined effects of bucillamine and etanercept on a rat type II collagen-induced arthritis model.
Setoguchi C; Tsuji F; Katsuta O; Okamoto M; Aono H
Mod Rheumatol; 2010 Aug; 20(4):381-8. PubMed ID: 20379758
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of Huang-Lian-Jie-Du-Tang and its component group on collagen-induced arthritis in rats.
Hu Y; Hu Z; Wang S; Dong X; Xiao C; Jiang M; Lv A; Zhang W; Liu R
J Ethnopharmacol; 2013 Dec; 150(3):1137-44. PubMed ID: 24212076
[TBL] [Abstract][Full Text] [Related]
17. Pro-apoptotic effect of epigallo-catechin-3-gallate on B lymphocytes through regulating BAFF/PI3K/Akt/mTOR signaling in rats with collagen-induced arthritis.
Liu D; Li P; Song S; Liu Y; Wang Q; Chang Y; Wu Y; Chen J; Zhao W; Zhang L; Wei W
Eur J Pharmacol; 2012 Sep; 690(1-3):214-25. PubMed ID: 22760071
[TBL] [Abstract][Full Text] [Related]
18. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
[TBL] [Abstract][Full Text] [Related]
19. CD200-Fc, a novel antiarthritic biologic agent that targets proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis.
Simelyte E; Criado G; Essex D; Uger RA; Feldmann M; Williams RO
Arthritis Rheum; 2008 Apr; 58(4):1038-43. PubMed ID: 18383359
[TBL] [Abstract][Full Text] [Related]
20. Curcumin attenuates inflammatory response in IL-1beta-induced human synovial fibroblasts and collagen-induced arthritis in mouse model.
Moon DO; Kim MO; Choi YH; Park YM; Kim GY
Int Immunopharmacol; 2010 May; 10(5):605-10. PubMed ID: 20188213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
